Endo International plc and Par Pharmaceutical Holdings, Inc. announced that they have reached a final agreement under which Endo will buy TPG Capital`s private company as part of an $8.05 billion deal. In 1994, TPG, Blum Capital and ACON Investments established Newbridge Capital, a joint venture to invest in emerging markets, including Asia and later Latin America. At its peak, Newbridge managed more than $3.2 billion. Newbridge is close to TPG in Fort Worth and San Francisco with investment offices throughout the Asia-Pacific region in Hong Kong, Melbourne, Mumbai, Seoul, Shanghai, Singapore and Tokyo. In 1995, Newbridge also ventured to Latin America, where it launched a $300 million fund in 1996 and a $150 million follow-up fund in 1996. After its debut in the mid-1990s, Newbridge no longer focused on Latin America. In 2018, Manipal Hospitals and TPG acquired Fortis Healthcare as part of a 3900 Rs deal   in early 2006, when TPG completed fundraising for its fifth private equity fund, co-founder Bill Price announced that he would reduce his work with the company.  The Endo/Par combination will create a leading specialty pharmaceutical company, one of the fastest growing companies in the industry and ranks in the top 5 in terms of U.S. revenue.
It is also expected to help drive long-term double-digit growth in Endo`s sales and provide a broad pipeline of products. In the past, TPG has relied primarily on private equity funds, pension fund pools, insurance, foundations, fund funds, high net worth individuals, sovereign wealth funds and other institutional investors. By the end of 2008, TPG had completed fundraising for more than 20 funds with a total commitment of more than $50 billion. In 2000, TPG completed the controversial acquisition of smart card maker Gemplus SA. TPG fought with the company`s founder, Marc Lassus, for control of the company.  Also in 2000, TPG completed an investment in Seagate Technology. Founded in 1992 by David Bonderman, James Coulter and William S. Price III, the company has raised $50 billion in investor commitments from more than 18 private equity funds.
 TPG entered film production in late 2004, when Metro-Goldwyn-Mayer took a larger acquisition by the Gunzis. A consortium led by TPG and Sony has completed the $4.81 billion purchase of the studio. The consortium also included media companies Providence Equity Partners and Quadrangle Group, as well as DLJ Merchant Banking Partners.  The transaction was announced in September 2004 and completed in early 2005. [Citation required] The transaction was unanimously approved by the boards of Endo and Par and is supported by the management teams of both companies. There is no need for further approval of shareholders. The purchase price will consist of approximately 18 million shares ($1.55 billion in value based on Endo`s weighted 10-day average share price through May 15, 2015) of endo equity and $6.50 billion to shareholders per. “This transaction with Par builds on our generic growth and adds a strong portfolio of high-barrier entry products and attractive gross margins, while transforming Endo and creating a successful business platform for future growth and strategic AM,” said Rajiv De Silva, President and Chief Executive Officer of Endo.
“We believe that the acquisition of Par underscores the continued implementation of Endo`s value-based D-A strategy and helps achieve our goal of double-digit revenue growth for the business as a whole.